These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 14999524)

  • 1. Serum osteoprotegerin (OPG) and the A163G polymorphism in the OPG promoter region are related to peripheral measures of bone mass and fracture odds ratios.
    Jørgensen HL; Kusk P; Madsen B; Fenger M; Lauritzen JB
    J Bone Miner Metab; 2004; 22(2):132-8. PubMed ID: 14999524
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Odds ratios for hip- and lower forearm fracture using peripheral bone densitometry; a case-control study of postmenopausal women.
    Saleh MM; Jørgensen HL; Lauritzen JB
    Clin Physiol Funct Imaging; 2002 Jan; 22(1):58-63. PubMed ID: 12003102
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of a common allelic polymorphism (C677T) in the methylene tetrahydrofolate reductase gene with a reduced risk of osteoporotic fractures. A case control study in Danish postmenopausal women.
    Jørgensen HL; Madsen JS; Madsen B; Saleh MM; Abrahamsen B; Fenger M; Lauritzen JB
    Calcif Tissue Int; 2002 Nov; 71(5):386-92. PubMed ID: 12232679
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Single nucleotide polymorphisms in the human gene for osteoprotegerin are not related to bone mineral density or fracture in elderly women.
    Brändström H; Gerdhem P; Stiger F; Obrant KJ; Melhus H; Ljunggren O; Kindmark A; Akesson K
    Calcif Tissue Int; 2004 Jan; 74(1):18-24. PubMed ID: 14508625
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum levels of osteoprotegerin and osteoprotegerin polymorphisms in Gaucher disease.
    Magal I; Lebel E; Altarescu G; Itzchaki M; Rudensky B; Foldes AJ; Zimran A; Elstein D
    Br J Haematol; 2006 Apr; 133(1):93-7. PubMed ID: 16512834
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circulating estradiol and osteoprotegerin as determinants of bone turnover and bone density in postmenopausal women.
    Rogers A; Saleh G; Hannon RA; Greenfield D; Eastell R
    J Clin Endocrinol Metab; 2002 Oct; 87(10):4470-5. PubMed ID: 12364420
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Osteoprotegerin (OPG)/RANK-L system in juvenile idiopathic arthritis: is there a potential modulating role for OPG/RANK-L in bone injury?
    Masi L; Simonini G; Piscitelli E; Del Monte F; Giani T; Cimaz R; Vierucci S; Brandi ML; Falcini F
    J Rheumatol; 2004 May; 31(5):986-91. PubMed ID: 15124262
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The risk of Colles' fracture is associated with the collagen I alpha1 Sp1 polymorphism and ultrasound transmission velocity in the calcaneus only in heavier postmenopausal women.
    Weichetova M; Stepan JJ; Haas T; Michalska D
    Calcif Tissue Int; 2005 Feb; 76(2):98-106. PubMed ID: 15570400
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polymorphisms in the osteoprotegerin gene are associated with osteoporotic fractures.
    Langdahl BL; Carstens M; Stenkjaer L; Eriksen EF
    J Bone Miner Res; 2002 Jul; 17(7):1245-55. PubMed ID: 12096838
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interleukin-6 promoter polymorphism is associated with bone quality assessed by calcaneus ultrasound and previous fractures in a cohort of 75-year-old women.
    Nordström A; Gerdhem P; Brändström H; Stiger F; Lerner UH; Lorentzon M; Obrant K; Nordström P; Akesson K
    Osteoporos Int; 2004 Oct; 15(10):820-6. PubMed ID: 14997289
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Osteoprotegerin and bone mass in squamous cell head and neck cancer patients.
    Valero C; Olmos JM; Rivera F; Hernández JL; Vega ME; Macías JG
    Calcif Tissue Int; 2006 Jun; 78(6):343-7. PubMed ID: 16830204
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circulating amounts of osteoprotegerin and RANK ligand: genetic influence and relationship with BMD assessed in female twins.
    Abrahamsen B; Hjelmborg JV; Kostenuik P; Stilgren LS; Kyvik K; Adamu S; Brixen K; Langdahl BL
    Bone; 2005 Apr; 36(4):727-35. PubMed ID: 15781001
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum osteoprotegerin levels in patients after liver transplantation and correlation to bone turnover, bone mineral density and fracture status.
    Fahrleitner A; Prenner G; Kniepeiss D; Iberer F; Tscheliessnigg KH; Piswanger-Sölkner C; Obermayer-Pietsch B; Leb G; Dobnig H
    Wien Klin Wochenschr; 2002 Aug; 114(15-16):717-24. PubMed ID: 12602117
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is A163G polymorphism in the osteoprotegerin gene associated with heel velocity of sound in postmenopausal women?
    Zajíčková K; Zemanová A; Hill M; Žofková I
    Physiol Res; 2008; 57 Suppl 1():S153-S157. PubMed ID: 18271681
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationships between the changes of serum levels of OPG and RANKL with age, menopause, bone biochemical markers and bone mineral density in Chinese women aged 20-75.
    Liu JM; Zhao HY; Ning G; Zhao YJ; Chen Y; Zhang Zh; Sun LH; Xu MY; Chen JL
    Calcif Tissue Int; 2005 Jan; 76(1):1-6. PubMed ID: 15455183
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The relationships between changes of serum osteoprotegerin, nuclear factor-kappa B ligand receptor activator, and age, menopause, bone biochemical markers and bone mineral densities in women aged 20 - 75].
    Liu JM; Zhao HY; Ning G; Zhao YJ; Chen Y; Zhang LZ; Xu MY; Chen JL
    Zhonghua Nei Ke Za Zhi; 2004 Jun; 43(6):447-50. PubMed ID: 15312444
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of three bone ultrasounds for the discrimination of subjects with and without osteoporotic fractures among 7562 elderly women.
    Krieg MA; Cornuz J; Ruffieux C; Sandini L; Büche D; Dambacher MA; Hartl F; Häuselmann HJ; Kraenzlin M; Lippuner K; Neff M; Pancaldi P; Rizzoli R; Tanzi F; Theiler R; Tyndall A; Wimpfheimer K; Burckhardt P
    J Bone Miner Res; 2003 Jul; 18(7):1261-6. PubMed ID: 12854836
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Variation in genes involved in the RANKL/RANK/OPG bone remodeling pathway are associated with bone mineral density at different skeletal sites in men.
    Hsu YH; Niu T; Terwedow HA; Xu X; Feng Y; Li Z; Brain JD; Rosen CJ; Laird N; Xu X
    Hum Genet; 2006 Jan; 118(5):568-77. PubMed ID: 16249885
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effect of osteoprotegerin gene polymorphism on bone mass in postmenopausal women].
    Cheng Q; Zhu HM; Miao YX; Zhu XY; Chen XP; Zhang XM
    Zhonghua Yi Xue Za Zhi; 2004 Feb; 84(4):274-7. PubMed ID: 15059506
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of A163G polymorphism in the osteoprotegerin gene on osteoporosis related traits in Slovak postmenopausal women.
    Krajcovicova V; Omelka R; Durisová J; Martiniakova M; Galbavy D; Bauerova M
    Anthropol Anz; 2015; 72(3):311-9. PubMed ID: 26131575
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.